Short Interest in NewAmsterdam Pharma (NASDAQ:NAMSW) Drops By 80.0%

NewAmsterdam Pharma (NASDAQ:NAMSW) was the recipient of a large drop in short interest in December. As of December 15th, there was short interest totalling 200 shares, a drop of 80.0% from the November 30th total of 1,000 shares. Based on an average daily trading volume, of 6,700 shares, the days-to-cover ratio is presently 0.0 days.

NewAmsterdam Pharma Stock Down 1.1 %

NAMSW stock traded down $0.16 during midday trading on Thursday, hitting $14.33. The company’s stock had a trading volume of 1,000 shares, compared to its average volume of 9,695. The stock’s 50-day moving average price is $10.98 and its 200 day moving average price is $8.99. NewAmsterdam Pharma has a 1 year low of $2.69 and a 1 year high of $16.75.

About NewAmsterdam Pharma

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases.